Zealand Pharma (ZLDPF) announced the appointment of Eric Rojas, Vice President, Investor Relations, effective April 15, 2026. Eric will report to Henriette Wennicke, CFO, and will be based in Massachusetts, U.S. He has held senior roles at several companies including Vertex Pharmaceuticals, Stoke Therapeutics, and Shire.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study
- Zealand Pharma establishes U.S. research hub in Cambridge, Massachusetts
- Zealand Pharma price target lowered to DKK 275 from DKK 450 at Deutsche Bank
- Zealand Pharma price target lowered to DKK 460 from DKK 1,000 at JPMorgan
- Zealand Pharma downgraded to Neutral from Outperform at BNP Paribas